![Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma]()
Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinomaAlva, Ajjai; Daniels, Gregory A.; Wong, Michael K. K.; Kaufman, Howard L.; Morse, Michael A.; McDermott, David F.; Clark, Joseph I.; Agarwala, Sanjiv S.; Miletello, Gerald; Logan, Theodore F.; Hauke, Ralph J.; Curti, Brendan; Kirkwood, John M.; Gonzalez, Rene; Amin, Asim; Fishman, Mayer; Agarwal, Neeraj; Lowder, James N.; Hua, Hong; Aung, Sandra; Dutcher, Janice P. · Cancer Immunology, Immunotherapy · 2016